In NSCLC (A549 and H460) cells, UA inhibits the EGFR/JAK2/STAT3 pathway to reduce tumor angiogenesis, migration and invasion, promote apoptosis and induce cell cycle arrest at G0/G1 phase [1063]. The gene discussed is JAK2; the disease is neoplasm.